Global Health Ltd, known for the Medanta brand, reported strong Q2 FY2027 results with revenue rising 33.6% to Rs 1,469.04 crore and net profit climbing 38.4% to Rs 219.14 crore. Alongside the earnings, the company approved a Rs 997 crore investment to build a 500-bed hospital in Ghaziabad, signaling a clear push for deeper penetration into the NCR market over the next four years.
Global Health Q2 Profit Rises 38% as Expansion Plans Firm Up
Consolidated net profit reached Rs 219.14 crore for Q2 FY2027.
Revenue from operations increased by 33.6% to Rs 1,469.04 crore.
Reader Takeaway: Strong operational growth supports a new Rs 997 crore Ghaziabad hospital project; watch debt funding levels.
What just happened
Global Health Ltd (Medanta) released its financial results for the quarter ended September 30, 2026, showing significant growth across key metrics. The company reported a net profit of Rs 219.14 crore, up from Rs 158.40 crore in the same quarter last year. Simultaneously, the board approved a capital-intensive plan to establish a 500-bed multi-specialty hospital in Ghaziabad, Uttar Pradesh, with a budget of Rs 997 crore.
Why this matters
The company is scaling its presence in the Delhi-NCR and Western UP region, identifying Ghaziabad as a vital referral catchment area. By committing nearly Rs 1,000 crore to this facility, management is signaling confidence in both the demand for high-end medical care and their own internal cash-flow generation. The project will be funded through a mix of internal accruals and debt.
The backstory
Over the past few quarters, Global Health has maintained a strategy of expanding its bed capacity in high-growth urban hubs. The land for the new Ghaziabad project was secured via the UP Housing & Development Board. Construction is slated to occur in a phased manner over the next three to four years.
Risks to watch
Investors should closely track the execution of the Ghaziabad project to ensure it remains within the projected budget and timeline. Additionally, as the company taps into debt to finance this expansion, shareholders should monitor interest coverage ratios and overall balance sheet health in subsequent quarterly filings.
What to track next
Watch for project commencement announcements, regulatory clearances for the new facility, and quarterly updates on the debt-to-equity ratio as capital expenditure ramps up.